HIPEC Cancer Surgery in India for Iraqis: What You Need to Know Before You Travel

Author:- Dr. Dheeraj Bojwani Date Created:- 14-08-2026

For a patient whose cancer, colorectal, ovarian, appendiceal, or stomach in origin, has spread across the lining of the abdomen, the diagnosis often arrives with the word “inoperable” attached. Peritoneal carcinomatosis was, until relatively recently, treated with palliative chemotherapy alone. Cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy, HIPEC, has changed that picture for a genuine subset of these patients, physically removing all visible tumour from the abdominal cavity and then bathing the area in heated chemotherapy to destroy microscopic disease left behind. This is one of the most demanding procedures in oncology, and it is performed well in only a small number of centres worldwide. I have spent 24 years guiding patients from across the Middle East, Africa, and South Asia through exactly this decision, and Iraqi families are an increasingly regular part of that work. What I tell every family calling from Baghdad, Basra, Erbil, or Sulaimani is the same thing I would tell my own relative: HIPEC is not a standard cancer surgery that any competent surgical oncologist can perform. It requires a dedicated peritoneal malignancy team, a surgeon who has completed a genuine volume of these specific cases, and a hospital equipped for the extended operating time and intensive post-operative care this surgery demands. For a growing number of Iraqi families facing this specific diagnosis, once the options are compared honestly, that team is found in India.

Healing Journeys of Iraqi Patients

Iraqi Patients Share Their Experience

Why Iraqi Patients Are Looking Beyond Iraq for HIPEC Cancer Surgery

Iraq has built real general oncology capacity in recent years, with centres such as Al Amal National Hospital for Cancer Management in Baghdad and the Oncology Teaching Hospital at Medical City providing surgery, chemotherapy, and radiation for a wide range of cancers. Many patients receive good general cancer care without ever leaving the country, and that should always be the first option a family investigates.

Where the picture becomes genuinely difficult is HIPEC specifically. This procedure depends on a dedicated peritoneal surface malignancy programme, specialised heated chemotherapy perfusion equipment, and a surgical and anaesthesia team experienced in operations that can run eight to twelve hours, followed by intensive care capable of managing a patient through a demanding recovery. This is a genuinely rare combination of infrastructure and sub-specialised training even in well-resourced healthcare systems, and it is not yet an established part of Iraq’s cancer treatment landscape. This is why Iraqi families facing peritoneal carcinomatosis specifically now travel for this procedure, and India has become one of the most trusted destinations, not simply the cheapest one.

Why India Specifically for HIPEC Cancer Surgery, Not Just Overseas

Iraqi families researching treatment abroad quickly discover several destinations: Turkey, Germany, and India are among those most commonly mentioned for this specific procedure. It is worth being direct about why India stands apart for HIPEC specifically.

The first reason is dedicated programme volume. India’s leading peritoneal malignancy centres perform a genuine, ongoing volume of HIPEC procedures across colorectal, ovarian, appendiceal, and gastric primary cancers, which matters enormously in a procedure where patient selection, the completeness of the cytoreductive surgery, and management of a long, complex operation all directly determine survival outcomes.

The second reason is integration with complete cancer care. Leading Indian HIPEC centres maintain surgical oncology, medical oncology, and radiology together, so patient selection for HIPEC, deciding who will genuinely benefit versus who would be better served by chemotherapy alone, is made by an experienced multidisciplinary team rather than a single surgeon’s judgment.

The third reason is infrastructure built specifically for international patients, including Arabic-speaking coordinators and case managers who can review existing imaging and pathology remotely to help confirm candidacy before a family ever travels. Finally, there is regulatory credibility: a large share of India’s leading cancer hospitals hold JCI or NABH accreditation, and many surgical oncologists have trained or held fellowships in the UK, US, or Germany specifically in peritoneal surface malignancy.

Understanding the Cost Picture of HIPEC Cancer Surgery in India

Cost is a genuine concern for most Iraqi families facing this diagnosis, and it is where India’s advantage is hardest to ignore. The figures below reflect typical all-inclusive ranges for cytoreductive surgery combined with HIPEC, covering the extended surgery, the heated chemotherapy perfusion, and intensive care stay. Costs vary considerably by the extent of disease and how much of the surgery is required, so I always urge families to get a written, itemised estimate once imaging has confirmed candidacy.

What stands out is not simply that India is cheaper than the United States, the United Kingdom, or Germany. It is that India offers the same specialised perfusion equipment and internationally trained peritoneal malignancy teams at a fraction of Western prices, with transparent, package-based pricing that contrasts favourably with Western systems where a quoted “surgery cost” often excludes the extended ICU stay this procedure requires until the final bill arrives. Many hospitals also accept a partial advance deposit rather than full upfront payment, which is worth raising directly in the first consultation since it can meaningfully ease the financial planning involved in arranging funds from Iraq.

What HIPEC Cancer Surgery in India Typically Looks Like

Families often worry most about the length and intensity of this specific surgery. Having coordinated this journey for many families, I find it helps enormously to see the process mapped out plainly before departure.

A typical HIPEC patient can expect an eight-to-twelve-hour surgery followed by several days in intensive care, with a total hospital stay of ten to fourteen days, and a further one to two weeks in India for recovery and a follow-up check before flying home, with a structured remote follow-up plan continuing afterward.

Factors Every Iraqi Patient Should Weigh Before Deciding HIPEC Cancer Surgery in India

Beyond cost and destination, the Iraqi families I have advised over these 24 years tend to make better decisions, and face fewer complications, when they think through the following before booking anything.

A few of these deserve a specific note. Ask directly how many HIPEC procedures the specific surgical team performs each year, and for which primary cancer types, since experience with colorectal-origin disease does not automatically transfer to ovarian or gastric-origin disease. Existing imaging and pathology reports should be translated and shared digitally before travel, since candidacy for this procedure depends heavily on the specific extent and pattern of disease. Families should also ask, in writing, what proportion of the quoted cost is contingent on the extent of disease actually found during surgery, since this can only be fully confirmed once the operation has begun.

A Closing Thought for Iraqi Families

HIPEC is among the most demanding procedures in modern oncology, and it deserves a dedicated, experienced team, not a general surgical oncologist attempting it occasionally or a marketing brochure promising the lowest quoted price. What the evidence consistently shows is that for Iraqi families facing peritoneal carcinomatosis, India offers a genuinely rare combination: dedicated programme volume, multidisciplinary patient selection, specialised equipment, and meaningfully lower cost than the West. Few destinations available to an Iraqi family today can offer this depth of peritoneal malignancy experience at once. My role, and the role of any advisor a family works with, should be to help confirm genuine candidacy honestly and make sure the plan in front of them fits the patient’s specific diagnosis, budget, and timeline. Iraq’s families deserve the same standard of scrutiny and care in this decision as any family anywhere else in the world.

Sources & Further Reading

• World Health Organization — Iraq Health System Profile (who.int/countries/irq)
• National Institute for Health and Care Excellence (NICE, UK) — Peritoneal Cancer Guidance (nice.org.uk)
• UK Government — List of English-Speaking Doctors and Medical Facilities in Iraq (gov.uk/government/publications/iraq-doctors-and-medical-facilities)
• National Cancer Institute (NCI, US) — Peritoneal Surface Malignancy Treatment (cancer.gov)
• World Bank — Iraq Health Sector Reports (worldbank.org/en/country/iraq)

Frequently Asked Questions by Iraqi Patients about HIPEC Cancer Surgery in India